🇺🇸 FDA

Intelligence · Clinical Pipeline

Phase II Pipeline Programs

Proof-of-concept and dose-finding clinical programs in Phase II development.

Programs
7,238

Quick answer

NovaPharmaNews tracks 7,238 phase ii pharmaceutical pipeline programs from ClinicalTrials.gov. Proof-of-concept and dose-finding clinical programs in Phase II development.

Top sponsors

Page 141 of 151

  1. alb-interferon alfa 2b

    Novartis Pharmaceuticals

    Chronic Hepatitis C

    phase 2 small molecule completed

    1 trial

  2. albiglutide

    GlaxoSmithKline

    Diabetes Mellitus, Type 2

    phase 2 mab completed

    1 trial

  3. albuterol inhalation powder

    Amphastar France Pharmaceuticals

    Asthma

    phase 2 small molecule completed

    1 trial

  4. aleniglipron or placebo

    Structure Therapeutics

    Obesity

    phase 2 small molecule completed

    1 trial

  5. alisertib

    Takeda

    Malignant Rhabdoid Tumor

    phase 2 small molecule active

    1 trial

  6. allogeneic human mesenchymal stem cells (hMSCs)

    United Therapeutics Europe Ltd

    Non-ischemic Dilated Cardiomyopathy

    phase 2 mab active

    1 trial

  7. allopurinol

    Ultragenyx UK Limited

    Leishmaniasis

    phase 2 small molecule completed

    1 trial

  8. alpha 1H, Placebo product for Alpha1H

    Lacuna Pharma Pty Ltd

    Non-muscle invasive bladder cancer awaiting transurethral surgery

    phase 2 small molecule active

    1 trial

  9. alprazolam

    BRIGHT MINDS BIOSCIENCES INC.

    Anxiety Disorder

    phase 2 small molecule completed

    1 trial

  10. alvimopan

    Merck KGaA, Darmstadt, Germany

    Constipation

    phase 2 small molecule completed

    1 trial

  11. aminomidazole carboxamide riboside

    Ultragenyx UK Limited

    Lesch-Nyhan Syndrome

    phase 2 small molecule completed

    1 trial

  12. amobarbital/Gel-One (one dose)

    United Therapeutics Europe Ltd

    Osteoarthritis

    phase 2 small molecule completed

    1 trial

  13. anagrelide hydrochloride

    Takeda

    Essential Thrombocythaemia

    phase 2 small molecule completed

    1 trial

  14. anastrozole

    Atrium Therapeutics

    Female Breast Carcinoma

    phase 2 small molecule active

    1 trial

  15. anlotinib

    Xiyuan Hospital of China Academy of Chinese Medical Sciences

    Sarcoma, Soft Tissue

    phase 2 small molecule active

    1 trial

  16. anlotinib

    Fudan University

    Extensive-stage Small Cell Lung Cancer

    phase 2 small molecule active

    1 trial

  17. anlotinib +TQB2450 + Oxaliplatin+S-1

    The First People's Hospital of Lianyungang

    Advanced Gastric or Gastroesophageal Junction (G/GEJ) Adenocarcinoma

    phase 2 small molecule active

    1 trial

  18. anlotinib combined with penpulimab

    The First People's Hospital of Lianyungang

    Non-small Cell Lung Cancer

    phase 2 small molecule active

    1 trial

  19. anlotinib+TQB2450+nab-paclitaxel+cisplatin

    The First People's Hospital of Lianyungang

    Advanced Biliary Tract Cancer

    phase 2 small molecule active

    1 trial

  20. anti-BCMA CAR-T

    Xiyuan Hospital of China Academy of Chinese Medical Sciences

    Plasma Cell Leukemia

    phase 2 mab active

    1 trial

  21. anti-BCMA-CAR-T

    Xiyuan Hospital of China Academy of Chinese Medical Sciences

    Multiple Myeloma

    phase 2 mab active

    2 trials

  22. anti-BCMA/CD3 bispecific antibody

    Xiyuan Hospital of China Academy of Chinese Medical Sciences

    Multiple Myeloma

    phase 2 small molecule active

    1 trial

  23. anti-CD133-CAR vector-transduced T cells

    Chinese PLA General Hospital

    Liver Cancer

    phase 2 mab completed

    1 trial

  24. anti-CD7 CAR-pNK cells

    The First People's Hospital of Lianyungang

    Acute Myeloid Leukemia

    phase 2 mab active

    1 trial

  25. anti-FLT3 CAR-T

    The First People's Hospital of Lianyungang

    Acute Myeloid Leukemia

    phase 2 mab active

    1 trial

  26. anti-IL8 mAb, Ipilimumab, anti-IL8 mAb, 5% dextrose solution for injection, OPDIVO 10 mg/mL concentrate for solution for infusion., Ipilimumab, 0.9% sodium chloride solution for injection

    Bristol-Myers Squibb Australia Pty Ltd

    Advanced solid tumors

    phase 2 small molecule active

    1 trial

  27. anti-MUC1 CAR-pNK cells

    The First People's Hospital of Lianyungang

    Hepatocellular Carcinoma

    phase 2 mab active

    1 trial

  28. anti-thymocyte globulin

    Ultragenyx UK Limited

    Fanconi's Anemia

    phase 2 small molecule completed

    1 trial

  29. anti-thymocyte globulin

    Ultragenyx UK Limited

    Systemic Sclerosis

    phase 2 small molecule completed

    1 trial

  30. arginine butyrate

    Ultragenyx UK Limited

    Beta-Thalassemia

    phase 2 small molecule completed

    1 trial

  31. armodafinil

    Teva Pharma GmbH

    Schizophrenia

    phase 2 small molecule completed

    2 trials

  32. artesunate

    Hospital Authority, Hong Kong

    Colorectal Cancer

    phase 2 small molecule active

    1 trial

  33. asparaginase Erwinia chrysanthemi

    Jazz Pharmaceuticals Ireland Limited

    Acute Lymphoblastic Leukemia

    phase 2 small molecule completed

    1 trial

  34. aspirin and atorvastatin

    United Therapeutics Europe Ltd

    Cardiovascular Risk Factor

    phase 2 small molecule active

    1 trial

  35. ataluren

    PTC THERAPEUTICS, INC.

    Epilepsy

    phase 2 small molecule completed

    1 trial

  36. atomoxetine

    BRIGHT MINDS BIOSCIENCES INC.

    Substance Abuse

    phase 2 small molecule completed

    1 trial

  37. atumelnant

    Crinetics Pharmaceuticals Europe GmbH

    Cushing Syndrome

    phase 2 small molecule active

    1 trial

  38. atumelnant (CRN04894)

    Crinetics Pharmaceuticals Europe GmbH

    Congenital Adrenal Hyperplasia

    phase 2 small molecule active

    2 trials

  39. auranofin

    Ultragenyx UK Limited

    Chronic Lymphocytic Leukemia (CLL)

    phase 2 small molecule completed

    1 trial

  40. autologous adipose-derived mesenchymal stem cell transplantation

    Hospital Authority, Hong Kong

    Aging Problems

    phase 2 mab active

    1 trial

  41. autologous anti-BCMA chimeric antigen receptor T cells

    The First People's Hospital of Lianyungang

    ITP

    phase 2 mab active

    1 trial

  42. autologous dendritic cells pulsed with tumor lysate antigen Vaccine

    NORTHWEST BIOTHERAPEUTICS INC

    Giant Cell Glioblastoma

    phase 2 mab terminated

    1 trial

  43. autologous mesenchymal stem cells implantation

    Teva Pharma GmbH

    Tibial Fracture

    phase 2 other completed

    1 trial

  44. autologous skin fibroblasts

    United Therapeutics Europe Ltd

    Wounds and Injuries

    phase 2 mab active

    1 trial

  45. avelumab

    Nektar Therapeutics UK Limited

    Squamous Cell Carcinoma of the Head and Neck (SCCHN)

    phase 2 small molecule terminated

    1 trial

  46. avelumab

    Samsung Bioepis NL B.V.

    Lymphoma, Extranodal NK-T-Cell

    phase 2 small molecule active

    1 trial

  47. avelumab (PD-L1 inhibitor immunotherapy) + lurbinectedin

    Jazz Pharmaceuticals Ireland Limited

    Metastatic Cancer

    phase 2 small molecule terminated

    1 trial

  48. azenosertib

    Zentalis Pharmaceuticals

    High-Grade Serous Ovarian, Fallopian Tube or Primary Peritoneal Cancer

    phase 2 small molecule active

    1 trial

Frequently asked questions

How many Phase II pipeline programs are in the directory?

7,238 published programs match this development stage in our ClinicalTrials.gov index.

What defines this pipeline stage?

Phase and status reflect ClinicalTrials.gov registry fields at last sync. See our clinical trial phases reference for methodology.

Data attribution: Data sources · All pipeline programs

Drug approvals, clinical trials, M&A, event intelligence, and company updates — weekly.

Customize topics & region
Topics
Region

No spam. Unsubscribe anytime. See our privacy policy.